These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10910925)

  • 1. Plasma levels of the differentiation inhibitory factor nm23-H1 protein and their clinical implications in acute myelogenous leukemia.
    Niitsu N; Okabe-Kado J; Nakayama M; Wakimoto N; Sakashita A; Maseki N; Motoyoshi K; Umeda M; Honma Y
    Blood; 2000 Aug; 96(3):1080-6. PubMed ID: 10910925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum nm23-H1 protein as a prognostic factor in hematological malignancies.
    Okabe-Kado J
    Leuk Lymphoma; 2002 Apr; 43(4):859-67. PubMed ID: 12153176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation by multivariate analysis of the differentiation inhibitory factor nm23 as a prognostic factor in acute myelogenous leukemia and application to other hematologic malignancies.
    Yokoyama A; Okabe-Kado J; Wakimoto N; Kobayashi H; Sakashita A; Maseki N; Nakamaki T; Hino Ki; Tomoyasu S; Tsuruoka N; Motoyoshi K; Nagata N; Honma Y
    Blood; 1998 Mar; 91(6):1845-51. PubMed ID: 9490665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation inhibitory factor nm23 as a new prognostic factor in acute monocytic leukemia.
    Yokoyama A; Okabe-Kado J; Sakashita A; Maseki N; Kaneko Y; Hino K; Tomoyasu S; Tsuruoka N; Kasukabe T; Honma Y
    Blood; 1996 Nov; 88(9):3555-61. PubMed ID: 8896423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation inhibitory factor Nm23 as a prognostic factor for acute myeloid leukemia.
    Okabe-Kado J; Kasukabe T; Honma Y
    Leuk Lymphoma; 1998 Dec; 32(1-2):19-28. PubMed ID: 10036998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic implications of the differentiation inhibitory factor nm23-H1 protein in the plasma of aggressive non-Hodgkin's lymphoma.
    Niitsu N; Okabe-Kado J; Kasukabe T; Yamamoto-Yamaguchi Y; Umeda M; Honma Y
    Blood; 1999 Nov; 94(10):3541-50. PubMed ID: 10552965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined analysis of differentiation inhibitory factor nm23-H1 and nm23-H2 as prognostic factors in acute myeloid leukaemia.
    Wakimoto N; Yokoyama A; Okabe-Kado J; Nagata N; Motoyoshi K; Honma Y
    Br J Cancer; 1998 Jun; 77(12):2298-303. PubMed ID: 9649149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated plasma level of differentiation inhibitory factor nm23-H1 protein correlates with risk factors for myelodysplastic syndrome.
    Ito Y; Okabe-Kado J; Honma Y; Iwase O; Shimamoto T; Ohyashiki JH; Ohyashiki K
    Leukemia; 2002 Feb; 16(2):165-9. PubMed ID: 11840281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated expression of differentiation inhibitory factor nm23 mRNA in monoblastic crisis of a patient with chronic myelogenous leukemia.
    Wakimoto N; Yokoyama A; Mukai Y; Kuwada N; Yamashita T; Matsumura T; Nakamura Y; Kanatani Y; Nagata N; Okabe-Kado J; Honma Y; Motoyoshi K
    Int J Hematol; 1998 Apr; 67(3):313-8. PubMed ID: 9650453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum nm23-H1 protein as a prognostic factor in aggressive non-Hodgkin lymphoma.
    Niitsu N; Okabe-Kado J; Okamoto M; Takagi T; Yoshida T; Aoki S; Hirano M; Honma Y
    Blood; 2001 Mar; 97(5):1202-10. PubMed ID: 11222361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of nm23 genes in acute myeloid leukemia and its clinical significance].
    Meng QX; Jiang R; Yang BQ; Zhang HY; Liu J; Pang LP; Wang J
    Zhonghua Xue Ye Xue Za Zhi; 2003 Jul; 24(7):369-71. PubMed ID: 12941193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The prognostic relation of nm23-H1/NDPK-A with leukemia and lymphoma].
    Li HY; Liu JS; Wang YF
    Sheng Li Ke Xue Jin Zhan; 2003 Jan; 34(1):74-7. PubMed ID: 12778818
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical significance of nm23-H1 proteins expressed on cell surface in non-Hodgkin's lymphoma.
    Niitsu N; Honma Y; Iijima K; Takagi T; Higashihara M; Sawada U; Okabe-Kado J
    Leukemia; 2003 Jan; 17(1):196-202. PubMed ID: 12529678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of nm23 gene expression during the induced differentiation of human leukemia cell lines.
    Yamashiro S; Urano T; Shiku H; Furukawa K
    Oncogene; 1994 Sep; 9(9):2461-8. PubMed ID: 8058309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of nm23 protein expression in renal cell carcinomas.
    Nakagawa Y; Tsumatani K; Kurumatani N; Cho M; Kitahori Y; Konishi N; Ozono S; Okajima E; Hirao Y; Hiasa Y
    Oncology; 1998; 55(4):370-6. PubMed ID: 9663430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum nm23-H1 protein as a prognostic factor for indolent non-Hodgkin's lymphoma.
    Niitsu N; Okamoto M; Okabe-Kado J; Takagi T; Yoshida T; Aoki S; Honma Y; Hirano M
    Leukemia; 2001 May; 15(5):832-9. PubMed ID: 11368446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased activity of nm23-H1 gene in squamous cell carcinoma of the head and neck is associated with advanced disease and poor prognosis.
    Pavelić K; Kapitanović S; Radosević S; Bura M; Seiwerth S; Pavelić LJ; Unusić J; Spaventi R
    J Mol Med (Berl); 2000; 78(2):111-8. PubMed ID: 10794547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of nm23-H1 is associated with poor prognosis in peripheral T-cell lymphoma.
    Niitsu N; Nakamine H; Okamoto M; Akamatsu H; Honma Y; Higashihara M; Okabe-Kado J; Hirano M;
    Br J Haematol; 2003 Nov; 123(4):621-30. PubMed ID: 14616965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular NM23 protein promotes the growth and survival of primary cultured human acute myelogenous leukemia cells.
    Okabe-Kado J; Kasukabe T; Honma Y; Kobayashi H; Maseki N; Kaneko Y
    Cancer Sci; 2009 Oct; 100(10):1885-94. PubMed ID: 19664043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nm23-h1 indirectly promotes the survival of acute myeloid leukemia blast cells by binding to more mature components of the leukemic clone.
    Lilly AJ; Khanim FL; Hayden RE; Luong QT; Drayson MT; Bunce CM
    Cancer Res; 2011 Feb; 71(3):1177-86. PubMed ID: 21169412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.